PARG and cancer: PARG and PARP have been reported to localize to sites of DNA damage (reviewed in [21]) and, intriguingly, mice deficient in PARG are hypersensitive to both -irradiation and alkylating agents [22], suggesting that high levels of PARG may contribute to resistance to DNA-damaging agents in cancer therapy.